Trials / Completed
CompletedNCT00283595
Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
Effect of Supraphysiological rhGH on Bone Metabolism in Patients With Anorexia Nervosa
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- Female
- Age
- 14 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Decreased bone strength is a serious medical problem present in many women with Anorexia Nervosa, or disordered eating. Women with weaker bones are more likely to suffer broken bones than women with normal bone strength. We are investigating whether a hormone that is naturally produced by the human body, called growth hormone, can help strengthen the bones of women with this type of disordered eating.
Detailed description
* Twelve week study * Eight visits, six of which can be conducted at your home physician's office * Two bone density scans * Hormonal and nutritional evaluations
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Recombinant Human Growth Hormone | Dosage increased in steps for first four weeks. Self injection qd x 12 weeks |
| DRUG | Placebo for Recombinant Human Growth Hormone | Administered as Arm 1, rHGH active Injection qd x 12 weeks Dosage increase over four weeks |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2006-01-30
- Last updated
- 2020-09-02
- Results posted
- 2012-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00283595. Inclusion in this directory is not an endorsement.